Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 5995
Single User License Price INR 419650
Corporate User License Price USD 17985
Corporate User License Price INR 1258950
Site License Price USD 11990
Site License Price INR 839300
Request a Quote

Report Title

EU5 Neuromodulation Devices Market Outlook to 2025

Quote Request for License Type
License Type Price  
Single User License USD 5995
Site License USD 11990
Enterprise Wide License USD 17985
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

EU5 Neuromodulation Devices Market Outlook to 2025


Quote Request for License Type
License Type Price  
Single User License USD 5995
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

EU5 Neuromodulation Devices Market Outlook to 2025

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

EU5 Neuromodulation Devices Market Outlook to 2025



Executive Summary

EU5 Neuromodulation Devices Market Outlook to 2025

Summary

GlobalData's new report, EU5 Neuromodulation Devices Market Outlook to 2025, provides key market data on the EU5 Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neuromodulation Devices market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Neuromodulation Devices market.

- Global corporate-level profiles of key companies operating within the EU5 Neuromodulation Devices market.

- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Neuromodulation Devices Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Neuromodulation Devices Market, EU5 7

3.1 Neuromodulation Devices Market, EU5, Revenue (USD m), 2015-2025 7

3.2 Neuromodulation Devices Market, EU5, Revenue (USD m), 2015-2025 9

3.3 Neuromodulation Devices Market, EU5, Volume (Units), 2015-2025 12

3.4 Neuromodulation Devices Market, EU5, Volume (Units), 2015-2025 14

3.5 Neuromodulation Devices Market, EU5, Company Share by Revenue (USD m), 2017 17

4 Neuromodulation Devices Market, France 19

4.1 Neuromodulation Devices Market, France, Revenue (USD m), 2015-2025 19

4.2 Neuromodulation Devices Market, France, Volume (Units), 2015-2025 22

4.3 Neuromodulation Devices Market, France, Average Price (USD ), 2015-2025 25

4.4 Neuromodulation Devices Market, France, Distribution Share by Revenue (USD m), 2017 27

4.5 Neuromodulation Devices Market, France, Company Share by Revenue (USD m), 2017 28

5 Neuromodulation Devices Market, Germany 30

5.1 Neuromodulation Devices Market, Germany, Revenue (USD m), 2015-2025 30

5.2 Neuromodulation Devices Market, Germany, Volume (Units), 2015-2025 33

5.3 Neuromodulation Devices Market, Germany, Average Price (USD ), 2015-2025 36

5.4 Neuromodulation Devices Market, Germany, Distribution Share by Revenue (USD m), 2017 38

5.5 Neuromodulation Devices Market, Germany, Company Share by Revenue (USD m), 2017 39

6 Neuromodulation Devices Market, Italy 41

6.1 Neuromodulation Devices Market, Italy, Revenue (USD m), 2015-2025 41

6.2 Neuromodulation Devices Market, Italy, Volume (Units), 2015-2025 44

6.3 Neuromodulation Devices Market, Italy, Average Price (USD ), 2015-2025 47

6.4 Neuromodulation Devices Market, Italy, Distribution Share by Revenue (USD m), 2017 49

6.5 Neuromodulation Devices Market, Italy, Company Share by Revenue (USD m), 2017 50

7 Neuromodulation Devices Market, Spain 52

7.1 Neuromodulation Devices Market, Spain, Revenue (USD m), 2015-2025 52

7.2 Neuromodulation Devices Market, Spain, Volume (Units), 2015-2025 55

7.3 Neuromodulation Devices Market, Spain, Average Price (USD ), 2015-2025 58

7.4 Neuromodulation Devices Market, Spain, Distribution Share by Revenue (USD m), 2017 60

7.5 Neuromodulation Devices Market, Spain, Company Share by Revenue (USD m), 2017 61

8 Neuromodulation Devices Market, United Kingdom 63

8.1 Neuromodulation Devices Market, United Kingdom, Revenue (USD m), 2015-2025 63

8.2 Neuromodulation Devices Market, United Kingdom, Volume (Units), 2015-2025 66

8.3 Neuromodulation Devices Market, United Kingdom, Average Price (USD ) , 2015-2025 69

8.4 Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue (USD m), 2017 71

8.5 Neuromodulation Devices Market, United Kingdom, Company Share by Revenue (USD m), 2017 72

9 Overview of Key Companies in EU5 Neuromodulation Devices Market 74

9.1 Medtronic Plc 74

9.2 Boston Scientific Corp 74

9.3 Nevro Corp 74

9.4 LivaNova PLC 74

9.5 Abbott Healthcare Pvt Ltd 75

10 Neuromodulation Devices Market Pipeline Products 76

11 Recent Developments 82

11.1 Corporate Communications 82

11.2 Financial Announcements 96

11.3 Government and Public Interest 138

11.4 Legal And Regulatory 139

11.5 Other Significant Developments 140

11.6 Product News 150

11.7 Strategy And Business Planning 151

12 Appendix 153

12.1 Research Methodology 154

12.2 GlobalData Consulting 158

12.3 Contact Us 159

12.4 Disclaimer 159

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

1.2 List of Figures

Figure 1: Neuromodulation Devices Market, Cross Country Comparison, EU5, Revenue (USD m), USD Constant, 2015-2025 9

Figure 2: Neuromodulation Devices Market, EU5, Revenue (USD m), Historic, USD Constant, 2015-2025 11

Figure 3: Neuromodulation Devices Market, EU5, Volume (Units), 2015-2025 14

Figure 4: Neuromodulation Devices Market, EU5, Volume (Units), 2015-2025 16

Figure 5: Neuromodulation Devices Market, EU5, Company Share (%) 2017 19

Figure 6: Neuromodulation Devices Market, France, Revenue (USD m), USD Constant, 2015-2025 21

Figure 7: Neuromodulation Devices Market, France, Volume (Units), 2015-2025 24

Figure 8: Neuromodulation Devices Market, France, Company Share (%) 2017 30

Figure 9: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2015-2025 32

Figure 10: Neuromodulation Devices Market, Germany, Volume (Units), 2015-2025 35

Figure 11: Neuromodulation Devices Market, Germany, Company Share (%) 2017 41

Figure 12: Neuromodulation Devices Market, Italy, Revenue (USD m), USD Constant, 2015-2025 43

Figure 13: Neuromodulation Devices Market, Italy, Volume (Units), 2015-2025 46

Figure 14: Neuromodulation Devices Market, Italy, Company Share (%) 2017 52

Figure 15: Neuromodulation Devices Market, Spain, Revenue (USD m), USD Constant, 2015-2025 54

Figure 16: Neuromodulation Devices Market, Spain, Volume (Units), 2015-2025 57

Figure 17: Neuromodulation Devices Market, Spain, Company Share (%) 2017 63

Figure 18: Neuromodulation Devices Market, United Kingdom, Revenue (USD m), USD Constant, 2015-2025 65

Figure 19: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2015-2025 68

Figure 20: Neuromodulation Devices Market, United Kingdom, Company Share (%) 2017 74

1.1 List of Tables

Table 1: Neuromodulation Devices Market, Cross Country Comparison, EU5, Revenue (USD m), USD Constant, 2015-2025 10

Table 2: Neuromodulation Devices Market, EU5, Revenue (USD m), Historic, USD Constant, 2015-2020 12

Table 3: Neuromodulation Devices Market, EU5, Revenue (USD m), Forecast, USD Constant, 2021-2025 13

Table 4: Neuromodulation Devices Market, EU5, Volume (Units), 2015-2025 15

Table 5: Neuromodulation Devices Market, EU5, Volume (Units), 2015-2020 17

Table 6: Neuromodulation Devices Market, EU5, Volume (Units), 2021-2025 18

Table 7: Neuromodulation Devices Market, EU5, Company Share by Revenue (USD m), USD Constant, 2017 20

Table 8: Neuromodulation Devices Market, France, Revenue (USD m), USD Constant, 2015-2020 22

Table 9: Neuromodulation Devices Market, France, Revenue (USD m), USD Constant, 2021-2025 23

Table 10: Neuromodulation Devices Market, France, Volume (Units), 2015-2020 25

Table 11: Neuromodulation Devices Market, France, Volume (Units), 2021-2025 26

Table 12: Neuromodulation Devices Market, France, Average Price (USD ), 2015-2020 27

Table 13: Neuromodulation Devices Market, France, Average Price (USD ), 2021-2025 28

Table 14: Neuromodulation Devices Market, France, Distribution Share by Revenue (USD m), USD Constant, 2017 29

Table 15: Neuromodulation Devices Market, France, Company Share by Revenue (USD m), USD Constant, 2017 31

Table 16: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2015-2020 33

Table 17: Neuromodulation Devices Market, Germany, Revenue (USD m), USD Constant, 2021-2025 34

Table 18: Neuromodulation Devices Market, Germany, Volume (Units), 2015-2020 36

Table 19: Neuromodulation Devices Market, Germany, Volume (Units), 2021-2025 37

Table 20: Neuromodulation Devices Market, Germany, Average Price (USD ), 2015-2020 38

Table 21: Neuromodulation Devices Market, Germany, Average Price (USD ), 2021-2025 39

Table 22: Neuromodulation Devices Market, Germany, Distribution Share by Revenue (USD m), USD Constant, 2017 40

Table 23: Neuromodulation Devices Market, Germany, Company Share by Revenue (USD m), USD Constant, 2017 42

Table 24: Neuromodulation Devices Market, Italy, Revenue (USD m), USD Constant, 2015-2020 44

Table 25: Neuromodulation Devices Market, Italy, Revenue (USD m), USD Constant, 2021-2025 45

Table 26: Neuromodulation Devices Market, Italy, Volume (Units), 2015-2020 47

Table 27: Neuromodulation Devices Market, Italy, Volume (Units), 2021-2025 48

Table 28: Neuromodulation Devices Market, Italy, Average Price (USD ), 2015-2020 49

Table 29: Neuromodulation Devices Market, Italy, Average Price (USD ), 2021-2025 50

Table 30: Neuromodulation Devices Market, Italy, Distribution Share by Revenue (USD m), USD Constant, 2017 51

Table 31: Neuromodulation Devices Market, Italy, Company Share by Revenue (USD m), USD Constant, 2017 53

Table 32: Neuromodulation Devices Market, Spain, Revenue (USD m), USD Constant, 2015-2020 55

Table 33: Neuromodulation Devices Market, Spain, Revenue (USD m), USD Constant, 2021-2025 56

Table 34: Neuromodulation Devices Market, Spain, Volume (Units), 2015-2020 58

Table 35: Neuromodulation Devices Market, Spain, Volume (Units), 2021-2025 59

Table 36: Neuromodulation Devices Market, Spain, Average Price (USD ), 2015-2020 60

Table 37: Neuromodulation Devices Market, Spain, Average Price (USD ), 2021-2025 61

Table 38: Neuromodulation Devices Market, Spain, Distribution Share by Revenue (USD m), USD Constant, 2017 62

Table 39: Neuromodulation Devices Market, Spain, Company Share by Revenue (USD m), USD Constant, 2017 64

Table 40: Neuromodulation Devices Market, United Kingdom, Revenue (USD m), USD Constant, 2015-2020 66

Table 41: Neuromodulation Devices Market, United Kingdom, Revenue (USD m), USD Constant, 2021-2025 67

Table 42: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2015-2020 69

Table 43: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2021-2025 70

Table 44: Neuromodulation Devices Market, United Kingdom, Average Price (USD ), 2015-2020 71

Table 45: Neuromodulation Devices Market, United Kingdom, Average Price (USD ), 2021-2025 72

Table 46: Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue (USD m), USD Constant, 2017 73

Table 47: Neuromodulation Devices Market, United Kingdom, Company Share by Revenue (USD m), USD Constant, 2017 75

Table 48: Neuromodulation Devices Market Pipeline Products 78

Table 49: Total Number of Primary Research Participants, Neurology Devices Market, by Country 158

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Medtronic Plc

Boston Scientific Corp

Nevro Corp

LivaNova PLC

Abbott Healthcare Pvt Ltd

Neurology Devices, Hydrocephalus shunts, Interventional Neuroradiology, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products, Radiosurgery Systems, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Natus Medical Incorporated, Stryker Corp, Nevro Corp, Cerenovus, Terumo Corp, LivaNova PLC , Nihon Kohden Corp, Penumbra Inc, Integra LifeSciences Corp, B. Braun Melsungen AG, Accuray Inc, Elekta AB


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person